| Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events M Guerrini, D Beccati, Z Shriver, A Naggi, K Viswanathan, A Bisio, I Capila, ... Nature biotechnology 26 (6), 669-675, 2008 | 704 | 2008 |
| Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin CJ Mycroft-West, D Su, I Pagani, TR Rudd, S Elli, NS Gandhi, ... Thrombosis and haemostasis 120 (12), 1700-1715, 2020 | 300 | 2020 |
| The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding C Mycroft-West, D Su, S Elli, Y Li, S Guimond, G Miller, J Turnbull, E Yates, ... BioRxiv, 2020.02. 29.971093, 2020 | 231 | 2020 |
| 1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives EA Yates, F Santini, M Guerrini, A Naggi, G Torri, B Casu Carbohydrate research 294, 15-27, 1996 | 225 | 1996 |
| Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase F Levy-Adam, G Abboud-Jarrous, M Guerrini, D Beccati, I Vlodavsky, ... Journal of Biological Chemistry 280 (21), 20457-20466, 2005 | 159 | 2005 |
| Preparation and characterization of poly (ethylene glycol)-crosslinked reacetylated chitosans A Dal Pozzo, L Vanini, M Fagnoni, M Guerrini, A De Benedittis, ... Carbohydrate Polymers 42 (2), 201-206, 2000 | 149 | 2000 |
| Conformation of heparin pentasaccharide bound to antithrombin III M HRICOVÍNI, M Guerrini, A Bisio, G TORRI, M PETITOU, B CASU Biochemical Journal 359 (2), 265-272, 2001 | 148 | 2001 |
| Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5 B Casu, G Grazioli, N Razi, M Guerrini, A Naggi, G Torri, P Oreste, F Tursi, ... Carbohydrate research 263 (2), 271-284, 1994 | 141 | 1994 |
| Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy M Guerrini, A Naggi, S Guglieri, R Santarsiero, G Torri Analytical biochemistry 337 (1), 35-47, 2005 | 137 | 2005 |
| Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy M Guerrini, S Guglieri, A Naggi, R Sasisekharan, G Torri Seminars in thrombosis and hemostasis 33 (05), 478-487, 2007 | 126 | 2007 |
| Combined quantitative 1H and 13C nuclear magnetic resonance spectroscopy for characterization of heparin preparations M Guerrini, A Bisio, G Torri Seminars in thrombosis and hemostasis 27 (05), 473-482, 2001 | 114 | 2001 |
| Orthogonal analytical approaches to detect potential contaminants in heparin M Guerrini, Z Zhang, Z Shriver, A Naggi, S Masuko, R Langer, B Casu, ... Proceedings of the National Academy of Sciences 106 (40), 16956-16961, 2009 | 110 | 2009 |
| Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells Y Nadir, B Brenner, S Gingis-Velitski, F Levy-Adam, N Ilan, E Zcharia, ... Thrombosis and haemostasis 99 (01), 133-141, 2008 | 110 | 2008 |
| In Vitro Antiplasmodial Activity of Extracts of Tristaniopsis Species and Identification of the Active Constituents: Ellagic Acid and 3,4,5-Trimethoxyphenyl-(6‘-O-galloyl)-O-β … L Verotta, M Dell'Agli, A Giolito, M Guerrini, P Cabalion, E Bosisio Journal of natural products 64 (5), 603-607, 2001 | 110 | 2001 |
| Undersulfated and glycol-split heparins endowed with antiangiogenic activity B Casu, M Guerrini, S Guglieri, A Naggi, M Perez, G Torri, G Cassinelli, ... Journal of medicinal chemistry 47 (4), 838-848, 2004 | 108 | 2004 |
| Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors B Casu, M Guerrini, A Naggi, M Perez, G Torri, D Ribatti, P Carminati, ... Biochemistry 41 (33), 10519-10528, 2002 | 107 | 2002 |
| Characterization and binding activity of the chondroitin/dermatan sulfate chain from Endocan, a soluble endothelial proteoglycan S Sarrazin, M Lyon, JA Deakin, M Guerrini, P Lassalle, M Delehedde, ... Glycobiology 20 (11), 1380-1388, 2010 | 105 | 2010 |
| Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction: Evidence for very high … M Guerrini, S Guglieri, B Casu, G Torri, P Mourier, C Boudier, C Viskov Journal of biological chemistry 283 (39), 26662-26675, 2008 | 99 | 2008 |
| Structural and conformational aspects of the anticoagulant and antithrombotic activity of heparin and dermatan sulfate B Casu, M Guerrini, G Torri Current pharmaceutical design 10 (9), 939-949, 2004 | 98 | 2004 |
| Structural features of low-molecular-weight heparins affecting their affinity to antithrombin A Bisio, D Vecchietti, L Citterio, M Guerrini, R Raman, S Bertini, G Eisele, ... Thrombosis and haemostasis 102 (11), 865-873, 2009 | 95 | 2009 |
